Sign Out
Tablet: Short-term treatment of the following conditions: Active duodenal ulcer, Active benign gastric ulcer, Gastroesophageal reflux disease (GERD) with or without esophagitis; Maintenance therapy of the following conditions: Duodenal ulcer after healing of an active ulcer, GERD; and treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine adenomas).
Injection: For some hospitalized patients with pathological hypersecretory conditions or intractable ulcers; For the short-term treatment of the following conditions when oral medication is not feasible: Treatment and maintenance of active duodenal ulcer, Active benign gastric ulcer, Treatment and maintenance therapy of GERD, Pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine adenomas) and Upper gastrointestinal bleeding (due to esophagitis)
Continue with Google